Clinical Study
Actual Incidence and Clinical Behaviour of Follicular Thyroid Carcinoma: An Institutional Experience
Table 1
Clinical, pathological, and follow-up data of all the included patients. Comparative analysis between MI-FTC and WI-FTC.
| | All patients | MI-FTC | WI-FTC | value |
| Patients | 130 | 66 | 64 | | Age (±SDa) (range) years | (18–88) | (28–76) | (18–88) | NS* | Male/female | 39/91 | 15/51 | 24/40 | NS* | Tumour size (± SDa) (range) mm | (5–100) | (5–70) | (11–100) | <0.001 | Distant metastasis at diagnosis | 4 | 1 | 3 | NS* | pT stage | | | | | T1/T2/T3 | 36/63/31 | 27/33/6 | 9/30/25 | <0.001 | pT1 | 36 | 27 | 9 | <0.001 | pT2 | 63 | 33 | 30 | NS* | pT3 | 31 | 6 | 25 | <0.001 | pN stage | | | | | NX/N0/N1 | 129/0/1 | 66/0/0 | 63/0/1 | NS* | pM stage | | | | | M0/M1 | 126/4 | 65/1 | 61/3 | NS* | Multifocal disease | 4 | 2 | 2 | NS* | Microcarcinoma | 7 | 5 | 2 | NS* | HCC | 63 | 25 | 38 | <0.05 | Concomitant PTC | 21 | 15 | 6 | NS* | Follow-up yes/no | 117/13 | 62/4 | 55/9 | NS* | Follow-up (±SDa) (range) months | (17–182) | (17–174) | (27–182) | NS* | RAI/no RAI | 105/12 | 54/8 | 51/3 | NS* | Distant metastasis at follow-up | 3 | 0 | 3 | NS* |
|
|
SDa: standard deviation; NS*: not significant.
|